Germany digging Leronlimab... https://www.anleg
Post# of 155581
(Total Views: 723)
Posted On: 04/05/2020 2:48:44 PM
Germany digging Leronlimab...
https://www.anlegerverlag.de/cytodyn-das-ist-...h-heilbar/
CytoDyn: That's the salvation - Corona finally curable ?!
from investor publisher , April 5 , 2020
CytoDyn is featured on all news programs this Sunday. The company has succeeded in developing or modifying a drug with Leronlimab in order to heal people infected with the corona virus! Finally! CytoDyn usually specializes in medicines and treatments for HIV patients, but in the wake of the corona crisis, of course, everything was immediately concentrated to treat the corona virus.
Now it is time! In the past few days, CytoDyn has only received positive feedback after using Leronlimab. The price for the required injection is currently around $ 1,200 and illustrates the huge sales perspective for the CytoDyn.
The CytoDyn share price has the very best chances to go through the roof in the short term. On March 26, when the closing price was still 0.86, the stock shot up to EUR 3.34 in the following days. Starting from the December low of the previous year at around EUR 0.25, this translates into an increase of 1,136%! On Friday, the stock even declined somewhat, opening up new entry opportunities.
https://www.anlegerverlag.de/cytodyn-das-ist-...h-heilbar/
CytoDyn: That's the salvation - Corona finally curable ?!
from investor publisher , April 5 , 2020
CytoDyn is featured on all news programs this Sunday. The company has succeeded in developing or modifying a drug with Leronlimab in order to heal people infected with the corona virus! Finally! CytoDyn usually specializes in medicines and treatments for HIV patients, but in the wake of the corona crisis, of course, everything was immediately concentrated to treat the corona virus.
Now it is time! In the past few days, CytoDyn has only received positive feedback after using Leronlimab. The price for the required injection is currently around $ 1,200 and illustrates the huge sales perspective for the CytoDyn.
The CytoDyn share price has the very best chances to go through the roof in the short term. On March 26, when the closing price was still 0.86, the stock shot up to EUR 3.34 in the following days. Starting from the December low of the previous year at around EUR 0.25, this translates into an increase of 1,136%! On Friday, the stock even declined somewhat, opening up new entry opportunities.
(6)
(0)